Publication:
CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation

cris.virtual.author-orcid0000-0003-3820-0297
cris.virtual.author-orcid0000-0001-5897-3647
cris.virtualsource.author-orcid787b1334-19ec-4b6b-ba72-d2aa2271798c
cris.virtualsource.author-orcidecf89b10-ddb5-4544-a9c3-895f34205b9b
cris.virtualsource.author-orcidd88a8532-b73c-448f-9c5e-6dd59004d437
cris.virtualsource.author-orcidd7eb2525-1641-41ca-a6fd-9f24a69b7f24
datacite.rightsopen.access
dc.contributor.authorFederzoni, Elena
dc.contributor.authorHumbert, Magali
dc.contributor.authorTorbett, Bruce E
dc.contributor.authorBehre, Gerhard
dc.contributor.authorFey, Martin
dc.contributor.authorTschan, Mario
dc.date.accessioned2024-10-14T16:13:55Z
dc.date.available2024-10-14T16:13:55Z
dc.date.issued2014
dc.description.abstractThe basic leucine zipper transcription factor CCAAT/enhancer binding protein alpha (CEBPA) codes for a critical regulator during neutrophil differentiation. Aberrant expression or function of this protein contributes to the development of acute myeloid leukemia (AML). In this study, we identified two novel unrelated CEBPA target genes, the glycolytic enzyme hexokinase 3 (HK3) and the krüppel-like factor 5 (KLF5) transcription factor, by comparing gene profiles in two cohorts of CEBPA wild-type and mutant AML patients. In addition, we found CEBPA-dependent activation of HK3 and KLF5 transcription during all-trans retinoic acid (ATRA) mediated neutrophil differentiation of acute promyelocytic leukemia (APL) cells. Moreover, we observed direct regulation of HK3 by CEBPA, whereas our data suggest an indirect regulation of KLF5 by this transcription factor. Altogether, our data provide an explanation for low HK3 and KLF5 expression in particular AML subtype and establish these genes as novel CEBPA targets during neutrophil differentiation.
dc.description.sponsorshipUniversitätsklinik für Medizinische Onkologie
dc.description.sponsorshipInstitut für Pathologie, Tumorpathologie
dc.description.sponsorshipDepartement Klinische Forschung, Forschungsgruppe Med. Onkologie / Hämatologie (Erw.)
dc.identifier.doi10.7892/boris.43709
dc.identifier.pmid24584857
dc.identifier.publisherDOI10.1038/srep04261
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/114671
dc.language.isoen
dc.publisherNature Publishing Group
dc.relation.ispartofScientific Reports
dc.relation.issn2045-2322
dc.relation.organizationDCD5A442BE58E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C448E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442C453E17DE0405C82790C4DE2
dc.relation.schoolDCD5A442C27BE17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleCEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.issue1
oaire.citation.startPage4261
oaire.citation.volume4
oairecerif.author.affiliationDepartement Klinische Forschung, Forschungsgruppe Med. Onkologie / Hämatologie (Erw.)
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
oairecerif.author.affiliationUniversitätsklinik für Medizinische Onkologie
oairecerif.author.affiliationInstitut für Pathologie, Tumorpathologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId43709
unibe.journal.abbrevTitleSci Rep
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
srep04261.pdf
Size:
882.83 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc-sa/4.0
Content:
published

Collections